Multiple Sclerosis Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People of any sex, aged between 18 and 50 years old.
- People who are in a stable phase of their condition and have not had a relapse in at least three months before their blood sample is taken.
- People who have been diagnosed with Multiple Sclerosis (MS), whether they are currently on medication for it or have never taken disease-modifying treatment, based on the McDonald 2024 diagnostic criteria.
- People diagnosed with MS based on the 2017 McDonald Criteria who have never received disease-modifying treatment for NMOSD (a related neurological condition) (confirm with trial site).
- People who are willing to provide written informed consent, with the study having approval from the ethics committee at the Faculty of Medicine, Assiut University.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have another condition that looks similar to MS or NMOSD.
- People who are unable or unwilling to attend follow-up visits and regular MRI scans as required by the trial.
- People who are not willing to sign the written informed consent form.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 0201151220581
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Primary endpoints
serum Glial Fibrillary Acidic Protein levels
Can't join this trial?
Data last synced from ClinicalTrials.gov: 17 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.